tirzepatide pregnancy use What are the risks of becoming pregnant while taking (glucagon-like peptide-1 receptor agonist)? tirzepatide pregnancy safety data Long-Term

GI adverse events most common

This is a popular therapy for those who are struggling to get enough fluids, which is not uncommon among people who take tirzepatide

Long-term supplementation with L-Carnitine provides beneficial support for the body to use fat for energy allowing to retain muscle mass and enabling better performance

this warrants ongoing monitoring No unexpected serious cardiovascular signals were identified during the limited Phase 2 follow-up period, though the trials were neither designed nor powered to assess cardiovascular outcomes, and longer-term data are not yet available At present, the overall safety profile appears broadly consistent with other GLP-1-based therapies, but definitive conclusions cannot be drawn until Phase 3 data and post-marketing surveillance are available